| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000033779 |
| Receipt No. | R000038529 |
| Official scientific title of the study | Comparison of glucose monitoring between insulin glargine U-300 and insulin degludec in the elderly patients with type 2 diabetes mellitus |
| Date of disclosure of the study information | 2018/08/28 |
| Last modified on | 2018/08/16 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Comparison of glucose monitoring between insulin glargine U-300 and insulin degludec in the elderly patients with type 2 diabetes mellitus | |
| Title of the study (Brief title) | Glucose monitoring in the elderly patients with type 2 diabetes mellitus using long-acting insulin | |
| Region |
|
|
| Condition | ||
| Condition | Type 2 diabetes mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Comparison of glucose monitoring between two types of long-acting insulin |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Mean amplitude of glycemic excursion |
| Key secondary outcomes | Mean of daily difference, average blood glucose, standard deviation, hypoglycemia with glucose value less than 70 mg/dl |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients requiring insulin glargine U-300 for 7 days | |
| Interventions/Control_2 | Patients requiring insulin degludec for 7 days | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients aged 65 and older treating with basal oral therapy using insulin glargine or insulin degludec | |||
| Key exclusion criteria | 1. Patients who have diabetic ketosis or diabetic coma.
2. Patients with severe infection, severe injury or perioperative state. 3. Patients with severe diabetic complications such as neuropathy, retinopathy, and nephropathy. 4. Patients with severe hepatic, kidney, or cardiac diseases. 5. Pregnant. 6. Patients whom researchers rule out as inappropriate subjects. |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroaki Yagyu |
| Organization | Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital |
| Division name | Endocrinology and Metabolism |
| Address | 3-2-7 Miya-machi, Mito, Ibaraki, Japan 310-0015 |
| TEL | 029-231-2371 |
| hiroakiyagyu@md.tsukuba.ac.jp | |
| Public contact | |
| Name of contact person | Masanao Fujii |
| Organization | Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital |
| Division name | Department of Endocrinology and Metabolism |
| Address | 3-2-7 Miyamachi, Mito, Ibaraki, Japan 310-0015 |
| TEL | 029-231-2371 |
| Homepage URL | |
| mfujii1224@gmail.com | |
| Sponsor | |
| Institute | Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Tsukuba University Hospital Mito Clinical Education and Training Center Mito Kyodo General Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038529 |